Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Alimera Sciences Inc has a consensus price target of $6 based on the ratings of 3 analysts. The high is $6 issued by HC Wainwright & Co. on June 25, 2024. The low is $6 issued by HC Wainwright & Co. on June 25, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Maxim Group on June 25, 2024, May 16, 2024, and March 25, 2024, respectively. With an average price target of $7.33 between HC Wainwright & Co., HC Wainwright & Co., and Maxim Group, there's an implied 31.30% upside for Alimera Sciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Alimera Sciences (NASDAQ:ALIM) was reported by Alliance Global Partners on June 25, 2024. The analyst firm set a price target for $0.00 expecting ALIM to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Alimera Sciences (NASDAQ:ALIM) was provided by Alliance Global Partners, and Alimera Sciences downgraded their neutral rating.
The last upgrade for Alimera Sciences Inc happened on June 12, 2023 when Alliance Global Partners raised their price target to $8. Alliance Global Partners previously had a neutral for Alimera Sciences Inc.
The last downgrade for Alimera Sciences Inc happened on June 25, 2024 when Alliance Global Partners changed their price target from N/A to N/A for Alimera Sciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on June 25, 2024 so you should expect the next rating to be made available sometime around June 25, 2025.
While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a downgraded with a price target of $0.00 to $0.00. The current price Alimera Sciences (ALIM) is trading at is $5.59, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.